MDR Tuberculosis: Critical Steps for Prevention and ControlNATHANSON, Eva; NUNN, Paul; UPLEKAR, Mukund et al.The New England journal of medicine. 2010, Vol 363, Num 11, pp 1050-1058, issn 0028-4793, 9 p.Article

Bedaquiline: A Novel Diarylquinoline for Multidrug-Resistant TuberculosisCHAHINE, Elias B; KARAOUI, Lamis R; MANSOUR, Hanine et al.The Annals of pharmacotherapy. 2014, Vol 48, Num 1, pp 107-115, issn 1060-0280, 9 p.Article

Nationwide survey of anti-tuberculosis drug resistance in MongoliaBUYANKHISHIG, B; NARANBAT, N; MITARAI, S et al.The International journal of tuberculosis and lung disease. 2011, Vol 15, Num 9, pp 1201-1205, issn 1027-3719, 5 p.Article

Resistance to anti-tuberculosis medications in the Horn of AfricaOLLE-GOIG, J. E; CODINA-GRAU, G; MARTIN-CASABONA, N et al.The International journal of tuberculosis and lung disease. 2011, Vol 15, Num 3, pp 414-416, issn 1027-3719, 3 p.Article

Surveillance for MDR-TB: is there an obligation to ensure treatment for individuals identified with MDR-TB?EDGINTON, M. E; MILLER, D. L; BURNEY, P et al.The International journal of tuberculosis and lung disease. 2010, Vol 14, Num 9, pp 1094-1096, issn 1027-3719, 3 p.Article

Outcome of hospitalized MDR-TB patients: Israel 2000-2005BENDAYAN, D; HENDLER, A; POLANSKY, V et al.European journal of clinical microbiology & infectious diseases (Print). 2011, Vol 30, Num 3, pp 375-379, issn 0934-9723, 5 p.Article

Fluoroquinolone and pyrazinamide resistance in multidrug-resistant tuberculosisPIERRE-AUDIGIER, C; SURCOUF, C; CADET-DANIEL, V et al.The International journal of tuberculosis and lung disease. 2012, Vol 16, Num 2, pp 221-223, issn 1027-3719, 3 p.Article

European Union Standards for Tuberculosis CareMIGLIORI, G. B; ZELLWEGER, J. P; KLIIMAN, K et al.The European respiratory journal. 2012, Vol 39, Num 4, pp 807-819, issn 0903-1936, 13 p.Article

Global survey of national tuberculosis drug policiesPAYDAR, A; MAK, A; AL JAHDALI, H et al.The International journal of tuberculosis and lung disease. 2011, Vol 15, Num 5, pp 613-619, issn 1027-3719, 7 p.Article

Recurrence after successful treatment among patients with multidrug-resistant tuberculosisLEE, J; LIM, H.-J; CHO, Y.-J et al.The International journal of tuberculosis and lung disease. 2011, Vol 15, Num 10, pp 1331-1333, issn 1027-3719, 3 p.Article

Tuberculosis drug-resistance in Lisbon, Portugal: a 6-year overviewPERDIGAO, J; MACEDO, R; SILVA, C et al.Clinical microbiology and infection. 2011, Vol 17, Num 9, pp 1397-1402, issn 1198-743X, 6 p.Article

Mechanism of multidrug recognition by MDR1/ABCB1KIMURA, Yasuhisa; MORITA, Shin-Ya; MATSUO, Michinori et al.Cancer science. 2007, Vol 98, Num 9, pp 1303-1310, issn 1347-9032, 8 p.Article

La Tuberculose multirésistante = Multiresistant tuberculosisBENFENATKI, N.La Revue de médecine interne (Paris). 2009, Vol 30, issn 0248-8663, S268-S272, SUP4Conference Paper

A targets framework: Dismantling the invisibility trap for children with drug-resistant tuberculosisBECERRA, Mercedes C; SWAMINATHAN, Soumya.Journal of public health policy. 2014, Vol 35, Num 4, pp 425-454, issn 0197-5897, 30 p.Article

Bedaquiline: A Novel Antitubercular Agent for the Treatment of Multidrug-Resistant TuberculosisWORLEY, Marylee V; ESTRADA, Sandy J.Pharmacotherapy. 2014, Vol 34, Num 11, pp 1187-1197, issn 0277-0008, 11 p.Article

Substandard and falsified anti-tuberculosis drugs: a preliminary field analysisBATE, R; JENSEN, P; HESS, K et al.The International journal of tuberculosis and lung disease. 2013, Vol 17, Num 3, pp 308-311, issn 1027-3719, 4 p.Article

Die soziale Dimension der Tuberkulose in der Stadt München = The Social Dimension of Tuberculosis in the City of MunichDREWECK, C; KERNER, E; GÜLLICH, K et al.Das Gesundheitswesen (Stuttgart. Thieme). 2013, Vol 75, Num 11, pp 689-692, issn 0941-3790, 4 p.Article

Place des fluoroquinolones dans le traitement des tuberculoses à bacilles résistants : La tuberculose en 2012 = Fluoroquinolone and drug-resistant tuberculosisFILLION, A; PANTEL, A; VEZIRIS, N et al.La Lettre du pneumologue. 2012, Vol 15, Num 1-2, pp 12-16, issn 1292-5977, 5 p.Article

Tuberculose multirésistante à l'hôpital d'instruction des armées de Libreville (Gabon) à propos de 16 cas = Multi-resistant tuberculosis at the hôpital d'instruction des armées de Libreville (Gabon) about 16 casesMOUNGUENGUI, D; ONDOUNDA, M; MANDJI LAWSON, J. M et al.Bulletin de la Société de pathologie exotique. 2012, Vol 105, Num 1, pp 1-4, issn 0037-9085, 4 p.Article

Emergence and treatment of multidrug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in South AfricaSTREICHER, Elizabeth M; MÜLLER, Borna; HELDEN, Paul D. Van et al.Infection, genetics and evolution (Print). 2012, Vol 12, Num 4, pp 686-694, issn 1567-1348, 9 p.Article

SILA 421, an inhibitor of efflux pumps of cancer cells, enhances the killing of intracellular extensively drug-resistant tuberculosis (XDR-TB)MARTINS, Marta; VIVEIROS, Miguel; RAMOS, Jorge et al.International journal of antimicrobial agents (Print). 2009, Vol 33, Num 5, pp 479-482, issn 0924-8579, 4 p.Article

Management of HIV-infected patients with MDR-and XDR-TB in resource-limited settingsSCANO, F; VITORIA, M; BURMAN, W et al.The International journal of tuberculosis and lung disease. 2008, Vol 12, Num 12, pp 1370-1375, issn 1027-3719, 6 p.Article

Delamanid: First Global ApprovalRYAN, Nicola J; JIN HAN LO.Drugs (Basel). 2014, Vol 74, Num 9, pp 1041-1045, issn 0012-6667, 5 p.Article

Tuberculose multirésistante et résection chirurgicale = Multiresistant tuberculosis and surgical resectionMORDANT, P; LE PIMPEC-BARTHES, F; RIQUET, M et al.Revue des maladies respiratoires. 2012, Vol 29, Num 10, pp 1272-1273, issn 0761-8425, 2 p.Article

Tuberculose multirésistante: à propos de 81 patients suivis dans un service de pneumologie en Côte d'Ivoire = Multi-drug resistance of tuberculosis: 81 patients monitored in an Ivory Coast pneumology unitHORO, K; AKA-DANGUY, E; KOFFI, N et al.Revue de pneumologie clinique (Paris). 2011, Vol 67, Num 2, pp 82-88, issn 0761-8417, 7 p.Article